Atomoxetine associated red ear: A case report

dc.contributor.authorTaner, Hande Ayraler
dc.contributor.authorSari, Burcu Akin
dc.contributor.orcID0000-0002-9730-7206en_US
dc.contributor.orcID0000-0003-2106-7928en_US
dc.contributor.researcherIDA-7296-2013en_US
dc.contributor.researcherIDW-9188-2019en_US
dc.date.accessioned2021-06-17T11:30:04Z
dc.date.available2021-06-17T11:30:04Z
dc.date.issued2020
dc.description.abstractRed ear syndrome is defined as mostly unilateral burning pain and redness of external ear. It has two forms idiopathic and secondary. Idiopathic red ear syndrome is mostly seen in young people and associated with migraine. Secondary red ear syndrome is more frequent in adults and releated with cervical disorder. Our patient was a 10 year old boy diagnosed with attention deficit hyperactivity disorder (ADHD) and spesific learning disorder. He had a complaint of redness in his ear, following the atomoxetine treatment for ADHD. The redness was appearing after taking atomoxetine in 1 hour. The redness in his ear was unilateral and lasted in 4 hours. Sometimes headaches were accompanied with red ear. After atomoxetine treatment was ceased the redness and the headache in his ear were dissappered. In the pathophysiology of red ear sydrome there is a disregulation of sympathic outflow. Atomoxetine has a high selectivity for noradrenergic receptors and also has an effect on periferic noradrenergic receptors. Atomoxetine could change the sympathic vasodilation/vasoconstruction balance and cause red ear. Although the red ear is not a life threating situation, it could cause discomfort and anxiety, so the clinicians should keep in mind red ear syndrome while using atomoxetine. To our best knowledge this is the first red ear case associated with atomoxetinein literature.en_US
dc.identifier.endpage235en_US
dc.identifier.issn1302-0099en_US
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85085986929en_US
dc.identifier.startpage232en_US
dc.identifier.urihttps://www.journalagent.com/z4/download_fulltext.asp?pdir=kpd&plng=eng&un=KPD-49932
dc.identifier.urihttp://hdl.handle.net/11727/6104
dc.identifier.volume23en_US
dc.identifier.wos000528247000014en_US
dc.language.isoengen_US
dc.relation.isversionof10.5505/kpd.2020.49932en_US
dc.relation.journalKLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAtomoxetineen_US
dc.subjectattention deficit hyperactivity disorderen_US
dc.subjectside effecten_US
dc.titleAtomoxetine associated red ear: A case reporten_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
KPD-49932-CASE_REPORT-AYRALER_TANER.pdf
Size:
55.02 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: